Coronary Artery Bypass Graft Market Report 2026

Coronary Artery Bypass Graft Market Overview

• Coronary Artery Bypass Graft market size has reached to $13.61 billion in 2025 • Expected to grow to $21.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Cardiovascular Disease Prevalence Sparks Surge In Coronary Artery Bypass Graft Market • Market Trend: Advancements in Coronary Artery Bypass Graft Market: Innovative Robotic Systems and AI Integration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Coronary Artery Bypass Graft Market?

A coronary artery bypass graft (CABG) is a surgical intervention to treat coronary artery disease. This procedure is conducted when the coronary arteries, responsible for delivering blood to the heart, become constricted or obstructed, potentially causing angina or a heart attack. The main procedures of the coronary artery bypass graft include single coronary artery bypass graft (CABG) surgery, double coronary artery bypass graft (CABG) surgery, triple coronary artery bypass graft (CABG) surgery, quadruple coronary artery bypass graft (CABG) surgery, and others. A single coronary artery bypass graft (CABG) surgery is a surgical intervention employed for the management of coronary heart disease. Off-pump and on-pump methods are used by hospitals, cardiology clinics, research institutes, and other end-users.

What Is The Coronary Artery Bypass Graft Market Growth Forecast?

The coronary artery bypass graft market size is expected to see strong growth in the next few years. It will grow to $21.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to advancements in surgical techniques, growing cardiac surgery volumes, improved patient outcomes, expansion of cardiac specialty centers, increasing healthcare expenditure. Major trends in the forecast period include growing adoption of minimally invasive cabg, increased use of off-pump procedures, rising demand for multi-vessel bypass surgeries, improved post-surgical recovery protocols, expansion of hybrid cardiac procedures.

Global Coronary Artery Bypass Graft Market Segmentation

1) By Procedure: Single Coronary Artery Bypass Graft (CABG) Surgery, Double Coronary Artery Bypass Graft (CABG) Surgery, Triple Coronary Artery Bypass Graft (CABG) Surgery, Quadruple Coronary Artery Bypass Graft (CABG) Surgery, Other Procedures 2) By Method: Off-pump, On-pump 3) By End-Use: Hospitals, Cardiology Clinics, Research Institutes, Other End-Users Subsegments: 1) By Single Coronary Artery Bypass Graft (CABG) Surgery: Left Internal Mammary Artery (LIMA) To Left Anterior Descending Artery (LAD) 2) By Double Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD and Another Artery 3) By Triple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Two Other Arteries 4) By Quadruple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Three Other Arteries 5) By Other Procedures: Off-Pump CABG, Minimally Invasive CABG, Hybrid Procedures

What Is The Driver Of The Coronary Artery Bypass Graft Market?

Increased prevalence of cardiovascular diseases is expected to drive the growth of the coronary artery bypass graft market going forward. Cardiovascular disease (CVD) broadly encompasses various heart and blood vessel ailments. A coronary artery bypass graft (CABG) is recommended to reduce the chances of having a heart attack by creating a new pathway for blood to flow around blocked or partially blocked arteries in the heart. For instance, in March 2023, according to the journal published by Oxford University Press, a UK-based university press of the University of Oxford, by 2045, the percentage of people affected with peripheral artery diseases would increase by 50%. Therefore, the increased prevalence of cardiovascular diseases is driving the growth of the coronary artery bypass graft industry.

Key Players In The Global Coronary Artery Bypass Graft Market

Major companies operating in the coronary artery bypass graft market are CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, Vitalitec International Medizintechnik GmbH

Global Coronary Artery Bypass Graft Market Trends and Insights

Major companies operating in the coronary artery bypass graft market are focused on developing innovative advancements such as surgical robotic systems to enhance precision and minimize invasiveness, improving patient outcomes. They are also exploring AI and minimally invasive techniques to optimize procedures and reduce recovery times. A surgical robotic system is a high-tech platform that assists surgeons in performing minimally invasive procedures with enhanced precision and visualization. It typically includes robotic arms, advanced imaging, and a console for the surgeon to control the instruments. For instance, in October 2023, SS Innovations International Inc., a US-based surgical and medical instrument manufacturing company, launched a SSi Mantra surgical robotic system. It is designed to provide advanced, cost-effective robotic surgery solutions across multiple specialties, including cardiac procedures. Its key benefits include enhanced surgical precision, reduced recovery times through minimally invasive techniques, and the integration of machine learning for improved safety and efficiency during operations.

What Are Latest Mergers And Acquisitions In The Coronary Artery Bypass Graft Market?

In February 2023, Kimal PLC, a UK-based manufacturer of vascular access devices and procedure packs, partnered with Marizyme, Inc. to gain exclusive distribution rights for DuraGraft in the United Kingdom. With this partnership, Kimal and Marizyme aim to combine Marizyme’s innovative vascular graft preservation technology with Kimal’s established distribution network to improve outcomes for patients undergoing coronary artery bypass graft (CABG) surgery. Marizyme Inc. is a US-based biomedical company focused on developing novel medical device technologies.

Regional Outlook

North America was the largest region in the coronary artery bypass graft market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Coronary Artery Bypass Graft Market?

The coronary artery bypass graft market consists of revenues earned by entities by providing services such as bypass grafts, peripheral vascular grafts, hemodialysis access grafts, and endovascular stent grafts. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary artery bypass graft market also includes sales of forceps, vascular forceps, grasping forceps, needle holders, scissors, and clamps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Coronary Artery Bypass Graft Market Report 2026?

The coronary artery bypass graft market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery bypass graft industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.